home / stock / mxct / mxct quote
Last: | $3.69 |
---|---|
Change Percent: | 1.87% |
Open: | $3.67 |
Close: | $3.69 |
High: | $3.75 |
Low: | $3.6 |
Volume: | 410,938 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.69 | $3.67 | $3.69 | $3.75 | $3.6 | 410,938 | 04-25-2024 |
$3.74 | $3.77 | $3.74 | $3.8 | $3.671 | 380,299 | 04-24-2024 |
$3.8 | $3.97 | $3.8 | $4.115 | $3.78 | 569,042 | 04-23-2024 |
$3.96 | $3.96 | $3.96 | $3.97 | $3.865 | 748,618 | 04-22-2024 |
$3.95 | $3.85 | $3.95 | $3.97 | $3.81 | 534,110 | 04-19-2024 |
$3.88 | $3.94 | $3.88 | $3.94 | $3.82 | 529,592 | 04-18-2024 |
$3.94 | $3.99 | $3.94 | $4.005 | $3.87 | 825,008 | 04-17-2024 |
$3.99 | $3.85 | $3.99 | $4.005 | $3.82 | 500,155 | 04-16-2024 |
$3.88 | $4 | $3.88 | $4 | $3.84 | 279,668 | 04-15-2024 |
$4 | $4.12 | $4 | $4.15 | $4 | 513,140 | 04-12-2024 |
$4.13 | $4.09 | $4.13 | $4.145 | $4.045 | 284,952 | 04-11-2024 |
$4.09 | $4.1 | $4.09 | $4.175 | $4.07 | 351,252 | 04-10-2024 |
$4.15 | $4.14 | $4.15 | $4.225 | $4.12 | 269,215 | 04-09-2024 |
$4.14 | $4.13 | $4.14 | $4.195 | $4.1 | 171,261 | 04-08-2024 |
$4.15 | $4.12 | $4.15 | $4.23 | $4.07 | 285,152 | 04-05-2024 |
$4.12 | $4.25 | $4.12 | $4.27 | $4.095 | 860,469 | 04-04-2024 |
$4.25 | $4.06 | $4.25 | $4.26 | $4.05 | 608,690 | 04-03-2024 |
$4.11 | $4.22 | $4.11 | $4.22 | $4.065 | 407,684 | 04-02-2024 |
$4.19 | $4.19 | $4.19 | $4.21 | $4.04 | 524,486 | 04-01-2024 |
$4.19 | $4.31 | $4.19 | $4.34 | $4.155 | 609,733 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
MaxCyte Inc. Company Name:
MXCT Stock Symbol:
NASDAQ Market:
ROCKVILLE, Md., April 10, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providi...
ROCKVILLE, Md., April 10, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioproc...
ROCKVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovat...